The defence lawyer for Martin Shkreli says the former pharmaceutical CEO would lose a $65-million US stake in a drug company he founded if he’s convicted at his securities fraud trial.
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy. I Agree